MacroGenics Provides Update on Corporate Progress and First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Macrogenics (MGNX) Extends Gain, Up 193%
May 6, 2020 12:49 PM EDTMacrogenics (NASDAQ: MGNX) Extends Gain, Up 193%
... MoreMacrogenics (MGNX) Tops Q1 EPS by 21c, Revenues Beat
May 5, 2020 5:23 PM EDTMacrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.81), $0.21 better than the analyst estimate of ($1.02). Revenue for the quarter came in at $13.68 million versus the consensus estimate of $9.54 million.
First Quarter 2020 Financial Results
Cash Position: Cash, cash equivalents and marketable securities as of March 31, 2020, were $170.8 million, compared to $215.8 million as of December 31, 2019. Revenue: Total revenue, consisting primarily of revenue from collaborative agreements, was $13.7 million for the quarter ended March 31, 2020, compared to $9.7 million for the quarter ended March 31, 2019. This increase was primarily due to revenue recognized for... More